Home>Topics>Companies>Novartis

Novartis NVS

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. BRIEF- Novartis says Alcon receives EU approval for lens in cataract patients

      Headlines

      Wed, 1 Jul 2015

      * Novartis International AG says Alcon unit receives European approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery Further company coverage: (Reporting By Zurich Slot)

    2. U.S. seeks up to $3.35 billion in Novartis kickback lawsuit

      Headlines

      Tue, 30 Jun 2015

      NEW YORK (Reuters) - The United States says Novartis AG should pay as much as $3.35 billion in damages and civil fines because the Swiss drugmaker used kickbacks to boost sales of two drugs covered by Medicare and Medicaid.

    3. U.S. seeks up to $3.35 billion in Novartis kickback lawsuit

      Headlines

      Tue, 30 Jun 2015

      NEW YORK, June 30 (Reuters) - The United States says Novartis AG should pay as much as $3.35 billion in damages and civil fines because the Swiss drugmaker used kickbacks to boost sales of two drugs covered by Medicare and Medicaid.

    4. BRIEF- Novartis launches smartwatch app for the visually impaired

      Headlines

      Tue, 30 Jun 2015

      * Novartis AG : launches the first app for visually impaired people for use with the Apple watch and other smart watches Further company coverage: (Reporting By Zurich Slot)

    5. UPDATE 1- Novartis buys pain drug firm Spinifex for $200 mln upfront

      Headlines

      Mon, 29 Jun 2015

      BASEL, Switzerland, June 29 (Reuters) - Swiss drugmaker Novartis AG boosted its presence in pain management on Monday by agreeing to buy U.S.-Australian biotech firm Spinifex Pharmaceuticals, the companies said in separate statements on Monday.

    6. Novartis agrees to buy biotech firm Spinifex Pharmaceuticals

      Headlines

      Mon, 29 Jun 2015

      ZURICH, June 29 (Reuters) - Swiss drugmaker Novartis AG will buy U.S.-Australian biotech company Spinifex Pharmaceuticals, a chronic pain specialist, the companies said in separate statements on Monday.

    7. New data fuel hopes for broad use of Novartis psoriasis drug

      Headlines

      Sun, 28 Jun 2015

      BASEL, Switzerland, June 29 (Reuters) - Novartis is increasingly confident about the potential of its new injectable drug Cosentyx, as fresh clinical data confirms its long-term benefits in treating psoriatic arthritis.

    8. Europe gives green light to new Novartis , Alexion drugs

      Headlines

      Fri, 26 Jun 2015

      LONDON, June 26 (Reuters) - New drugs from Novartis and Alexion won a green light from European regulators on Friday, delivering a boost to both drugmakers and offering new treatment options for...

    9. BRIEF-EU Medicines Agency backs Novartis' multiple myeloma drug

      Headlines

      Fri, 26 Jun 2015

      * Recommends approval of Novartis ag 's multiple myeloma durg farydak

    10. Maintaining Our Fair Value Estimate as Akorn Works Through Restatement Issues

      Commentary

      Tue, 23 Jun 2015

      The company recently hired a new vice president and corporate controller, Randall Pollard, who will oversee accounting and reporting functions. Pollard has previous financial leadership experience at Novartis , Wyeth, and Mayne Pharma.

    « Prev12345Next »
    Content Partners